Coverage
Filings
Danish vaccine maker Bavarian Nordic will supply an undisclosed European country with its smallpox and mpox vaccine under a new contract valued at over 200 million Danish Krone, the company announced Wednesday.
Danish vaccine company Bavarian Nordic has entered an agreement to sell a Priority Review Voucher for a total of $160 million, the company said Wednesday.
| 7 Nov 2019 |
| Bavarian Nordic A/S – Notice Convening Extraordinary General Meeting | 25 Oct 2019 |
| Bavarian Nordic Announces a Transformative Acquisition of Two Established Commercial Vaccines from GlaxoSmithKline | 21 Oct 2019 |
| Bavarian Nordic Updates on Phase 2 Study of CV301 in Bladder Cancer | 18 Oct 2019 |
| Bavarian Nordic Announces Initiation of Phase 1 Clinical Trial of Equine Encephalitis Virus Vaccine | 8 Oct 2019 |
| Bavarian Nordic Announces U.S. FDA Approval of JYNNEOS™ (Smallpox and Monkeypox Vaccine, Live, Non-replicating) for Prevention of Smallpox and Monkeypox Disease in Adults | 24 Sept 2019 |